133 related articles for article (PubMed ID: 34020962)
1. Feasibility of investigating methylphenidate for the treatment of sarcoidosis-associated fatigue (the FaST-MP study): a double-blind, parallel-arm randomised feasibility trial.
Atkins C; Jones A; Clark AB; Stockl A; Fordham R; Wilson AM
BMJ Open Respir Res; 2021 May; 8(1):. PubMed ID: 34020962
[TBL] [Abstract][Full Text] [Related]
2. Feasibility study of a randomised controlled trial to investigate the treatment of sarcoidosis-associated fatigue with methylphenidate (FaST-MP): a study protocol.
Atkins C; Fordham R; Clark AB; Stockl A; Jones AP; Wilson AM
BMJ Open; 2017 Dec; 7(12):e018532. PubMed ID: 29208618
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial.
Nourbakhsh B; Revirajan N; Morris B; Cordano C; Creasman J; Manguinao M; Krysko K; Rutatangwa A; Auvray C; Aljarallah S; Jin C; Mowry E; McCulloch C; Waubant E
Lancet Neurol; 2021 Jan; 20(1):38-48. PubMed ID: 33242419
[TBL] [Abstract][Full Text] [Related]
4. Phase II, randomised, double-blind, placebo-controlled trial of methylphenidate for reduction of fatigue levels in patients with prostate cancer receiving LHRH-agonist therapy.
Richard PO; Fleshner NE; Bhatt JR; Hersey KM; Chahin R; Alibhai SM
BJU Int; 2015 Nov; 116(5):744-52. PubMed ID: 24684534
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease.
Breitbart W; Rosenfeld B; Kaim M; Funesti-Esch J
Arch Intern Med; 2001 Feb; 161(3):411-20. PubMed ID: 11176767
[TBL] [Abstract][Full Text] [Related]
6. Double-blind, randomized trial of dexmethylphenidate hydrochloride for the treatment of sarcoidosis-associated fatigue.
Lower EE; Harman S; Baughman RP
Chest; 2008 May; 133(5):1189-95. PubMed ID: 18263672
[TBL] [Abstract][Full Text] [Related]
7. Improved cancer-related fatigue in a randomised clinical trial: methylphenidate no better than placebo.
Centeno C; Rojí R; Portela MA; De Santiago A; Cuervo MA; Ramos D; Gandara A; Salgado E; Gagnon B; Sanz A
BMJ Support Palliat Care; 2022 Jun; 12(2):226-234. PubMed ID: 33168668
[TBL] [Abstract][Full Text] [Related]
8. Effects of methylphenidate on fatigue and depression: a randomized, double-blind, placebo-controlled trial.
Kerr CW; Drake J; Milch RA; Brazeau DA; Skretny JA; Brazeau GA; Donnelly JP
J Pain Symptom Manage; 2012 Jan; 43(1):68-77. PubMed ID: 22208450
[TBL] [Abstract][Full Text] [Related]
9. Armodafinil for sarcoidosis-associated fatigue: a double-blind, placebo-controlled, crossover trial.
Lower EE; Malhotra A; Surdulescu V; Baughman RP
J Pain Symptom Manage; 2013 Feb; 45(2):159-69. PubMed ID: 22917711
[TBL] [Abstract][Full Text] [Related]
10. A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer.
Mar Fan HG; Clemons M; Xu W; Chemerynsky I; Breunis H; Braganza S; Tannock IF
Support Care Cancer; 2008 Jun; 16(6):577-83. PubMed ID: 17972110
[TBL] [Abstract][Full Text] [Related]
11. Treatment of fatigue with methylphenidate, modafinil and amantadine in multiple sclerosis (TRIUMPHANT-MS): Study design for a pragmatic, randomized, double-blind, crossover clinical trial.
Nourbakhsh B; Revirajan N; Waubant E
Contemp Clin Trials; 2018 Jan; 64():67-76. PubMed ID: 29113955
[TBL] [Abstract][Full Text] [Related]
12. Methylphenidate improves fatigue scores in Parkinson disease: a randomized controlled trial.
Mendonça DA; Menezes K; Jog MS
Mov Disord; 2007 Oct; 22(14):2070-6. PubMed ID: 17674415
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Methylphenidate on Fatigue in Advanced Cancer: An Aggregated N-of-1 Trial.
Mitchell GK; Hardy JR; Nikles CJ; Carmont SA; Senior HE; Schluter PJ; Good P; Currow DC
J Pain Symptom Manage; 2015 Sep; 50(3):289-96. PubMed ID: 25896104
[TBL] [Abstract][Full Text] [Related]
14. Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial.
Moreau C; Delval A; Defebvre L; Dujardin K; Duhamel A; Petyt G; Vuillaume I; Corvol JC; Brefel-Courbon C; Ory-Magne F; Guehl D; Eusebio A; Fraix V; Saulnier PJ; Lagha-Boukbiza O; Durif F; Faighel M; Giordana C; Drapier S; Maltête D; Tranchant C; Houeto JL; Debû B; Sablonniere B; Azulay JP; Tison F; Rascol O; Vidailhet M; Destée A; Bloem BR; Bordet R; Devos D;
Lancet Neurol; 2012 Jul; 11(7):589-96. PubMed ID: 22658702
[TBL] [Abstract][Full Text] [Related]
15. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial.
Bruera E; Valero V; Driver L; Shen L; Willey J; Zhang T; Palmer JL
J Clin Oncol; 2006 May; 24(13):2073-8. PubMed ID: 16648508
[TBL] [Abstract][Full Text] [Related]
16. 5-EPIFAT trial protocol: a multi-center, randomized, placebo-controlled trial of the efficacy of pharmacotherapy for fatigue using methylphenidate, bupropion, ginseng, and amantadine in advanced cancer patients on active treatment.
Miladinia M; Jahangiri M; White SJ; Karimpourian H; Inno A; Chan SW; Ganji R; Maniati M; Zarea K; Ghalamkari M; Farahat A; Fagerström C
Trials; 2024 Apr; 25(1):230. PubMed ID: 38570861
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of a 20-mg dose of methylphenidate for the treatment of daytime sleepiness in adult patients with myotonic dystrophy type 1: a 2-center, randomized, double-blind, placebo-controlled, 3-week crossover trial.
Puymirat J; Bouchard JP; Mathieu J
Clin Ther; 2012 May; 34(5):1103-11. PubMed ID: 22578232
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, 2-period, placebo-controlled crossover trial of a sustained-release methylphenidate in the treatment of fatigue in cancer patients.
Escalante CP; Meyers C; Reuben JM; Wang X; Qiao W; Manzullo E; Alvarez RH; Morrow PK; Gonzalez-Angulo AM; Wang XS; Mendoza T; Liu W; Holmes H; Hwang J; Pisters K; Overman M; Cleeland C
Cancer J; 2014; 20(1):8-14. PubMed ID: 24445757
[TBL] [Abstract][Full Text] [Related]
19. Sleep disturbance in patients with cancer: a feasibility study of multimodal therapy.
Yennurajalingam S; Carmack C; Balachandran D; Eng C; Lim B; Delgado M; Guzman Gutierrez D; Raznahan M; Park M; Hess KR; Williams JL; Lu Z; Ochoa J; Bruera E
BMJ Support Palliat Care; 2021 Jun; 11(2):170-179. PubMed ID: 31924662
[TBL] [Abstract][Full Text] [Related]
20. Methylphenidate and/or a nursing telephone intervention for fatigue in patients with advanced cancer: a randomized, placebo-controlled, phase II trial.
Bruera E; Yennurajalingam S; Palmer JL; Perez-Cruz PE; Frisbee-Hume S; Allo JA; Williams JL; Cohen MZ
J Clin Oncol; 2013 Jul; 31(19):2421-7. PubMed ID: 23690414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
